Actively Recruiting

Phase Not Applicable
Age: 1Month - 12Months
All Genders
ID06641687

Oral Sucrose for Pain Management During Flexible Nasolaryngoscopy in Infants

Led by The Hospital for Sick Children · Updated on 2025-07-04

60

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying whether oral sucrose (sugar water containing 24% sucrose) can reduce pain and distress in infants undergoing flexible nasolaryngoscopy, a procedure used to examine the nasal and throat areas. This study takes place in an outpatient setting at the SickKids Pediatric Otolaryngology Clinic and aims to understand how sucrose affects pain scores and other measures in babies during this procedure. Participants will be randomly assigned to receive either sterile water without sugar (placebo) or sugar water with 24% sucrose before the nasolaryngoscopy. The sucrose solution is not classified as a drug by Health Canada. The study uses a quadruple masking method, meaning that participants, caregivers, and researchers do not know which solution is given. This helps compare the effects of the sugar water to sterile water more accurately. During the study visit, researchers will measure pain scores, crying time, heart rate, time to baseline, skin conductance, visit duration, and caregiver impressions in infants up to 7 months old. Caregivers provide consent, and infants are monitored closely during and after the procedure to assess these outcomes. The total participation spans the scheduled clinic appointment when the flexible nasolaryngoscopy is performed.

CONDITIONS

Brief Title

Be Sweet to Babies During Nasolaryngoscopy

Who Can Participate

Age: 1Month - 12Months
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient less than 12 months of age
  • Scheduled for an appointment with specific pediatric otolaryngologists or a complex airway nurse practitioner at the Hospital for Sick Children
  • Requiring flexible nasolaryngoscopy for diagnostic purposes
  • Accompanied by caregivers who provided consent
Not Eligible

You will not qualify if you...

  • Patient older than 12 months of age
  • Infants younger than 37 weeks corrected gestational age
  • Infants with decreased consciousness or delayed neuromuscular development limiting pain response
  • Infants who had urgent airway assessments such as for respiratory distress or foreign body
  • Infants who received topical anesthesia (decongestant or anesthetic spray)
  • Infants with conditions contraindicating oral sucrose, including carbohydrate intolerance, absent gag reflex, non-functional gastrointestinal tract, history of aspiration or tracheoesophageal fistula, and necrotizing enterocolitis
  • Infants without parental consent or who declined randomization
  • Infants with severe respiratory distress
  • Infants with post-palliative systemic artery to pulmonary artery shunt
  • Infants with single ventricle congenital heart disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) during a scheduled appointment

Treatment

Duration - 1 day (during the scheduled clinic visit)

Participants receive either oral sucrose (24% sugar water) or sterile water as a placebo during flexible nasolaryngoscopy to manage pain and distress.

1 visit (in-person) during a scheduled appointment

Follow-up

Duration - Up to 7 months

Participants are observed for pain scores, crying time, heart rate, and other outcomes for up to 7 months after the procedure.

Follow-up assessments may occur during or after clinic visits up to 7 months

Trial Site Locations

Total: 1 location

1

The Hospital for Sick Children

Toronto, Ontario, Canada, M5G 1E8

Actively Recruiting

Loading map...

Research Team

N

Nikolaus E. Wolter, MD

M

Mary-Elizabeth Vanderpost, RN

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

Advanced Wireless Sensors for Neonatal Care in the Delivery ...

Sudden Unexplained Infant Death

Actively Recruiting

5 locations

Pharmacokinetics and Pharmacodynamics of Digoxin in Infants ...

Single-ventricle

Actively Recruiting

2 locations

Center of Excellence in Thai Pediatric Gastroenterology, Hep...

Functional Gastrointestinal Disorders

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here